Hans Eriksson

In this engaging discussion, Hans Eriksson, Chief Medical Officer at HMNC Brain Health, shares insights into precision psychiatry aimed at creating personalized treatment plans for depression. He addresses the power of predictive diagnostics and genetics in improving outcomes. The conversation highlights innovative antidepressants and breakthrough AI-driven tools that have the potential to reshape mental health care. Eriksson also discusses the critical role of biomarkers like ABCB1 and the exciting research into HPA axis-targeted therapies.